NM_138386.3:c.1375C>T

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_138386.3(NAF1):​c.1375C>T​(p.His459Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000691 in 1,447,248 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.00041 ( 0 hom., cov: 21)
Exomes 𝑓: 0.000032 ( 0 hom. )

Consequence

NAF1
NM_138386.3 missense

Scores

3
16

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 1.45

Publications

0 publications found
Variant links:
Genes affected
NAF1 (HGNC:25126): (nuclear assembly factor 1 ribonucleoprotein) Enables identical protein binding activity and telomerase RNA binding activity. Involved in regulation of nucleobase-containing compound metabolic process; ribosome biogenesis; and telomerase holoenzyme complex assembly. Located in nucleoplasm. Part of sno(s)RNA-containing ribonucleoprotein complex. [provided by Alliance of Genome Resources, Apr 2022]
NAF1 Gene-Disease associations (from GenCC):
  • pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 7
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.120710164).
BS2
High AC in GnomAd4 at 58 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NAF1NM_138386.3 linkc.1375C>T p.His459Tyr missense_variant Exon 8 of 8 ENST00000274054.3 NP_612395.2 Q96HR8-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NAF1ENST00000274054.3 linkc.1375C>T p.His459Tyr missense_variant Exon 8 of 8 1 NM_138386.3 ENSP00000274054.2 Q96HR8-1
NAF1ENST00000422287.6 linkc.1034-1892C>T intron_variant Intron 7 of 7 1 ENSP00000408963.2 Q96HR8-2
NAF1ENST00000509434.5 linkc.114+8192C>T intron_variant Intron 2 of 2 3 ENSP00000427518.1 D6RIB3
NAF1ENST00000509884.1 linkn.*113C>T downstream_gene_variant 5

Frequencies

GnomAD3 genomes
AF:
0.000412
AC:
58
AN:
140722
Hom.:
0
Cov.:
21
show subpopulations
Gnomad AFR
AF:
0.00143
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000218
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000503
AC:
8
AN:
159146
AF XY:
0.0000704
show subpopulations
Gnomad AFR exome
AF:
0.000886
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000321
AC:
42
AN:
1306526
Hom.:
0
Cov.:
30
AF XY:
0.0000404
AC XY:
26
AN XY:
644120
show subpopulations
African (AFR)
AF:
0.00122
AC:
36
AN:
29578
American (AMR)
AF:
0.00
AC:
0
AN:
33790
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
21860
East Asian (EAS)
AF:
0.00
AC:
0
AN:
27916
South Asian (SAS)
AF:
0.00
AC:
0
AN:
79138
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
39874
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3718
European-Non Finnish (NFE)
AF:
0.00000196
AC:
2
AN:
1018860
Other (OTH)
AF:
0.0000772
AC:
4
AN:
51792
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
3
6
8
11
14
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000412
AC:
58
AN:
140722
Hom.:
0
Cov.:
21
AF XY:
0.000367
AC XY:
25
AN XY:
68118
show subpopulations
African (AFR)
AF:
0.00143
AC:
55
AN:
38586
American (AMR)
AF:
0.000218
AC:
3
AN:
13774
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3342
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4226
South Asian (SAS)
AF:
0.00
AC:
0
AN:
3878
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
8806
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
306
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
64964
Other (OTH)
AF:
0.00
AC:
0
AN:
1960
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.519
Heterozygous variant carriers
0
3
6
8
11
14
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000142
Hom.:
0
Bravo
AF:
0.000453
ExAC
AF:
0.0000266
AC:
3

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Uncertain:1
May 20, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.1375C>T (p.H459Y) alteration is located in exon 8 (coding exon 8) of the NAF1 gene. This alteration results from a C to T substitution at nucleotide position 1375, causing the histidine (H) at amino acid position 459 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

not provided Uncertain:1
Nov 06, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces histidine, which is basic and polar, with tyrosine, which is neutral and polar, at codon 459 of the NAF1 protein (p.His459Tyr). This variant is present in population databases (rs771014519, gnomAD 0.1%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with NAF1-related conditions. ClinVar contains an entry for this variant (Variation ID: 2043821). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.082
BayesDel_addAF
Benign
-0.43
T
BayesDel_noAF
Benign
-0.41
CADD
Benign
21
DANN
Uncertain
1.0
DEOGEN2
Benign
0.0087
T
Eigen
Benign
-0.067
Eigen_PC
Benign
-0.049
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Benign
0.52
T
M_CAP
Benign
0.026
D
MetaRNN
Benign
0.12
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.5
L
PhyloP100
1.4
PrimateAI
Uncertain
0.71
T
PROVEAN
Benign
-0.89
N
REVEL
Benign
0.088
Sift
Benign
0.040
D
Sift4G
Benign
1.0
T
Polyphen
0.99
D
Vest4
0.31
MVP
0.45
MPC
0.22
ClinPred
0.058
T
GERP RS
4.2
Varity_R
0.064
gMVP
0.22
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs771014519; hg19: chr4-164050159; API